Drugs / Platelet Enhanced Plasma
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03866824 | Apr 2019 → Mar 2021 | osteoarthritis, knee | Assistance Publique Hopitaux De Marseille | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Platelet Enhanced Plasma | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03866824 ↗ |
| Known as | PRP | “Platelet Enhanced Plasma (PRP) is an autologous biological product” NCT03866824 ↗ |
| Modality | Other / unclassified | “autologous biological product” NCT03866824 ↗ |
| Route | Other | “intra-articular injection” NCT03866824 ↗ |